GL
Price
$121.84
Change
+$0.61 (+0.50%)
Updated
May 9, 03:31 PM (EDT)
Capitalization
10.73B
75 days until earnings call
MET
Price
$77.97
Change
+$0.38 (+0.49%)
Updated
May 9, 03:10 PM (EDT)
Capitalization
53.28B
82 days until earnings call
Ad is loading...

GL vs MET

Header iconGL vs MET Comparison
Open Charts GL vs METBanner chart's image
Globe Life
Price$121.84
Change+$0.61 (+0.50%)
Volume$479
Capitalization10.73B
MetLife
Price$77.97
Change+$0.38 (+0.49%)
Volume$550
Capitalization53.28B
GL vs MET Comparison Chart
Loading...
GL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GL vs. MET commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GL is a Buy and MET is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (GL: $121.23 vs. MET: $77.59)
Brand notoriety: GL: Not notable vs. MET: Notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: GL: 83% vs. MET: 105%
Market capitalization -- GL: $10.73B vs. MET: $53.28B
GL [@Life/Health Insurance] is valued at $10.73B. MET’s [@Life/Health Insurance] market capitalization is $53.28B. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $133.31B to $0. The average market capitalization across the [@Life/Health Insurance] industry is $24.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GL’s FA Score shows that 2 FA rating(s) are green whileMET’s FA Score has 1 green FA rating(s).

  • GL’s FA Score: 2 green, 3 red.
  • MET’s FA Score: 1 green, 4 red.
According to our system of comparison, MET is a better buy in the long-term than GL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GL’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 6 bullish TA indicator(s).

  • GL’s TA Score: 4 bullish, 5 bearish.
  • MET’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MET is a better buy in the short-term than GL.

Price Growth

GL (@Life/Health Insurance) experienced а +2.98% price change this week, while MET (@Life/Health Insurance) price change was +3.16% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.02%. For the same industry, the average monthly price growth was +6.82%, and the average quarterly price growth was +2.04%.

Reported Earning Dates

GL is expected to report earnings on Jul 23, 2025.

MET is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Life/Health Insurance (+0.02% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MET($53.3B) has a higher market cap than GL($10.7B). MET has higher P/E ratio than GL: MET (40.71) vs GL (11.33). GL YTD gains are higher at: 9.163 vs. MET (-3.927). MET has more cash in the bank: 308B vs. GL (18.1B). GL has less debt than MET: GL (2.12B) vs MET (18.8B). MET has higher revenues than GL: MET (66.4B) vs GL (5.45B).
GLMETGL / MET
Capitalization10.7B53.3B20%
EBITDAN/AN/A-
Gain YTD9.163-3.927-233%
P/E Ratio11.3340.7128%
Revenue5.45B66.4B8%
Total Cash18.1B308B6%
Total Debt2.12B18.8B11%
FUNDAMENTALS RATINGS
GL vs MET: Fundamental Ratings
GL
MET
OUTLOOK RATING
1..100
8513
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
5617
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
2549
P/E GROWTH RATING
1..100
2195
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MET's Valuation (41) in the Life Or Health Insurance industry is somewhat better than the same rating for GL (79) in the null industry. This means that MET’s stock grew somewhat faster than GL’s over the last 12 months.

MET's Profit vs Risk Rating (17) in the Life Or Health Insurance industry is somewhat better than the same rating for GL (56) in the null industry. This means that MET’s stock grew somewhat faster than GL’s over the last 12 months.

GL's SMR Rating (95) in the null industry is in the same range as MET (99) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to MET’s over the last 12 months.

GL's Price Growth Rating (25) in the null industry is in the same range as MET (49) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to MET’s over the last 12 months.

GL's P/E Growth Rating (21) in the null industry is significantly better than the same rating for MET (95) in the Life Or Health Insurance industry. This means that GL’s stock grew significantly faster than MET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMET
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Ad is loading...
GL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OB3.530.16
+4.75%
Outbrain
AMTB17.710.43
+2.49%
Amerant Bancorp
COO82.921.67
+2.06%
Cooper Companies (The)
MEIP2.080.03
+1.46%
MEI Pharma
ENOV33.08-1.16
-3.39%
Enovis Corp